乌鸦传媒

Oncology/Hematology

<乌鸦传媒 class='mpt-top_cat_title_description'>News, opinions and meeting coverage in oncology/hematology.

ESMO GI over a computer rendering of an endoscope illuminating a tumor in a stomach

<乌鸦传媒>PD-1 Inhibitor Boosts Survival in Treated Esophageal Cancer

Benefit with China-developed tislelizumab in all patients and EU-North American subgroup

A nurse injects medication into the IV of a mature woman receiving infusion therapy

<乌鸦传媒>Infusion Centers or EDs for Sickle Cell Crises?

Adults with SCD treated in infusion centers had improved outcomes in three key measures

COVID-19 UPDATE and Other News over a background of illustrated coronaviruses

<乌鸦传媒>COVID Surges Emerge; FDA Warns About Chantix; Lions, Tigers, Bears Get Vaxxed

A daily roundup of news on COVID-19 and the rest of medicine

CT imaging of primary ameloblastoma with measurement and three-dimensional reconstruction.

<乌鸦传媒>Woman Loses 6-Year Battle With Mouth Tumor

Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions

ESMO GI over a computer rendering of an endoscope illuminating a tumor in a stomach

<乌鸦传媒>Are Antibiotics Linked to Early-Onset Colorectal Cancer?

With cases increasing globally, researchers look to these commonly used drugs

ESHRE over a microscope image of embryo selection for in vitro fertilization

<乌鸦传媒>IVF Babies at No Increased Risk of Childhood Cancers

No associations seen with intracytoplasmic sperm injection or frozen embryo transfer, study found

A coal waste pile West of Trevorton, Pennsylvania.

<乌鸦传媒>House Members Argue for Puerto Rico Coal Plant Shutdown

Plant is releasing toxic coal ash, sickening the nearby community, lawmakers and witnesses say

ESMO GI over a computer rendering of an endoscope illuminating a tumor in a stomach

<乌鸦传媒>'Clinically Meaningful' Survival Gain in Neuroendocrine Tumors

Near 1-year improvement with radionuclide agent misses statistical significance

ESMO GI over a computer rendering of an endoscope illuminating a tumor in a stomach

<乌鸦传媒>Adjuvant Combo Boosts Survival in Resected Pancreatic Cancer

Four-month gain in OS with the addition of nab-paclitaxel to gemcitabine

A computed tomography scan showing a malignant tumor in the lung of a male heavy smoker

<乌鸦传媒>LDCT Screening Linked to Lower Risk of Brain Mets in Lung Cancer

This observed reduction in risk may be due to a less aggressive tumor biology, said study author

<乌鸦传媒>Do 'Robots' Offer Any Clear Surgical Advantage?

Review says no, and Vinay Prasad believes it's a sobering reflection on medical technology

EASL over a computer rendering of a liver

<乌鸦传媒>Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCC

"Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab

Two suburban houses side by side at the end of a cul-de-sac

<乌鸦传媒>Ethics Consult: Help Family Have 'Savior Child' for Marrow Donation? MD/JD Weighs In

You voted, now see the results and an expert's discussion

FDA ODAC over a PET scan of squamous carcinoma of the anal canal

<乌鸦传媒>Hold Off on Approving Anal Cancer Drug, Advisors Tell FDA

ODAC recommends deferring approval of new PD-1 inhibitor until confirmatory trial results are in

A 3 layer pill with ixazomib, lenalidomide, and dexamethasone etched into it over a microscopy of multiple myeloma.

<乌鸦传媒>No Survival Benefit With All-Oral Regimen for Relapsed/Refractory Myeloma

Prolonging PFS a positive, as advances make OS improvement harder to achieve

Radiologists in front of a computer monitor establishing the radiotherapy treatment area using a treatment planning system.

<乌鸦传媒>AI for Radiation Therapy Works, but Is it Fully Trusted?

Most machine learning-generated plans selected over human plans in head-to-head comparison

Cancer cells with OncoBreak in the center.

<乌鸦传媒>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival

News, features, and commentary about cancer-related issues

A computer rendering of the male reproductive system with a cross section of the prostate which has a tumor.

<乌鸦传媒>What's Guiding Prostate Cancer Care for Gay Men?

Research specific to this group has only scratched the surface

EHA over a computer rendering of red blood cells flowing through an artery

<乌鸦传媒>Fixed-Duration, All-Oral Regimen Slows CLL Progression

Near-80% reduction in PFS hazard with ibrutinib-venetoclax versus obinutuzumab-chlorambucil

An FDA APPROVED seal over a photo of prescription bottles on a shelf

<乌鸦传媒>The FDA Is Failing the American People

The agency's recent decision to approve aducanumab offers more evidence of a broken system

EHA over a computer rendering of red blood cells flowing through an artery

<乌鸦传媒>How CAR T-Cell Therapy Measures Up in Follicular Lymphoma

Better response rates and survival with axicabtagene ciloleucel versus external control group

EHA over a computer rendering of red blood cells flowing through an artery

<乌鸦传媒>Zanubrutinib Tops Ibrutinib in Relapsed or Refractory CLL

Better overall response rate, less cardiotoxicity, with second-generation BTK inhibitor

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Tweaking Maintenance Options in Metastatic CRC

Two studies move the needle, but no major breakthroughs

A senior woman visits with her female gynecologist.

<乌鸦传媒>Most Older Women Do Not Meet Criteria to Stop Cervical Cancer Screening

Inadequate screening in middle age, lack of medical record documentation highlighted

Cancer cells with OncoBreak in the center.

<乌鸦传媒>COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care?

News, features, and commentary about cancer-related issues

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Bispecific Antibody Active in NRG1-Positive Pancreatic Cancer

Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Promising Early Data for Bladder-Sparing Cancer Treatment

Bladder-intact DFS at 1 year nears 90% for muscle-invasive bladder cancer

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>TRK Inhibitor Proves Beneficial in Primary CNS Tumors

One-year OS rate with larotrectinib was 85%

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>New Standard for Metastatic Castration-Sensitive Prostate Cancer?

Triplet regimen reduced the risk for radiographic progression or death, but OS data await

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>More Support for Gene Assay to Guide Breast Cancer Treatment

More nuanced data on treatment de-escalation, extended endocrine therapy

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Another CAR-T Impresses in Follicular Lymphoma

Complete responses in 66% of patients with relapsed or refractory disease

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>BPAs Cut Fracture Risk in Metastatic Prostate Cancer

Those receiving enzalutamide with and without radium-223 saw benefits in updated safety analysis

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Acalabrutinib Offers Less Wear and Tear on the Heart in CLL Patients

BTK inhibitor had less cardiotoxicity than ibrutinib, but similar efficacy

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Adjuvant Anti-PD-1 Misses on OS in High-Risk Melanoma

But pembrolizumab topped active controls for relapse-free survival

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Combination Shows Promise in Post-Osimertinib Lung Cancer

Responses in 36% with amivantamab-lazertinib, 47% with EGFR/MET resistance

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Novel CDK 4/6 Inhibitor Proves Mettle in HR+/HER2- Advanced Breast Cancer

Dalpiciclib may be a new treatment option; palbociclib and ribociclib continue to shine

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Perioperative Chemo Enough in Esophageal Cancer?

MAGIC/FLOT regimens yielded similar overall survival to multimodal CROSS regimen

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>CAR-T Drives High Response in Relapsed/Refractory ALL

ZUMA-3 study shows brexucabtagene autoleucel offers long-term clinical benefit

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Antibody-Drug Conjugate Active in Resistant Lung Cancer

Responses in 39% of EGFR inhibitor-resistant patients with patritumab deruxtecan

ASCO over a computer rendering of a cancer cell and lymphocytes

<乌鸦传媒>Chemoimmunotherapy Tied to Better Outcomes in Advanced NSCLC

PD-L1 status and age play key roles in success of combined regimen versus immunotherapy alone

鈥�

46

鈥�